Autologous Stem Cell Transplant clinical trials

Explore recruiting autologous stem cell transplant clinical trials.

Recruiting autologous stem cell transplant studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Autologous Stem Cell Transplant trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM) (EXCALIBER-Maintenance)

Portugal, Spain, Denmark, Austria, Italy, Belgium +10 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase II multicenter study of carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy, followed by high-dose therapy with melphalan and autologous peripheral blood stem cell transplantation, consolidation with KRd, and maintenance with lenalidomide and dexamethasone in patients ≤ 70 years old with smoldering multiple myeloma (SMM) with high risk of progression to symptomatic myeloma

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

EORTC-1407-GUCG: A randomized phase III trial comparing conventional-dose chemotherapy using paclitaxel, ifosfamide, and cisplatin (TIP) with high-dose chemotherapy using mobilizing paclitaxel plus ifosfamide followed by high-dose carboplatin and etoposide (TI-CE) as first salvage treatment in relapsed or refractory germ cell tumors (TIGER)

Germany, Netherlands, France, Ireland, Belgium, Spain +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3 Study Comparing Lenalidomide and Daratumumab Subcutaneous Injection (R-Dara SC) vs Lenalidomide and Dexamethasone (Rd) in Frail Subjects with Previously Untreated Multiple Myeloma who are Ineligible for High Dose Therapy.

France, Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

A RANDOMIZED, MULTICENTER, OPEN LABEL STUDY COMPARING TWO STANDARD TREATMENTS, BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) WITH OR WITHOUT DARATUMUMAB (Dara-VMP) VS LENALIDOMIDE-DEXAMETHASONE (Rd) WITH OR WITHOUT DARATUMUMAB (Dara-Rd) IN AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) INELIGIBLE COMMUNITY POPULATION AFFECTED BY MULTIPLE MYELOMA (MM) – Real MM

Italy

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3 Randomized Study Comparing Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Ciltacabtagene Autoleucel versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in Participants with Newly Diagnosed Multiple Myeloma who are Transplant Eligible

Spain, France, Netherlands, Czechia, Sweden, Germany +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Autologous Stem Cell Transplant trials by city

Autologous Stem Cell Transplant in Toronto Autologous Stem Cell Transplant in Vancouver Autologous Stem Cell Transplant in Montreal Autologous Stem Cell Transplant in Calgary Autologous Stem Cell Transplant in Edmonton Autologous Stem Cell Transplant in Ottawa Autologous Stem Cell Transplant in Winnipeg Autologous Stem Cell Transplant in Quebec City Autologous Stem Cell Transplant in Hamilton Autologous Stem Cell Transplant in Kitchener Autologous Stem Cell Transplant in London Autologous Stem Cell Transplant in Halifax Autologous Stem Cell Transplant in New York Autologous Stem Cell Transplant in Los Angeles Autologous Stem Cell Transplant in Chicago Autologous Stem Cell Transplant in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease